Sign Up for Free!

Continue Analyzing the page and more.

Continue with Google

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Upgrade to Pro
Home Daily Intelligence Tracker
    • Plans Blog Contact
    XOMA Corp logo

    XOMA Corp

    US$25.40

    US$301.2m

    0.12%

    1.43%

    Transparent research score

    MaveScore

    A research prioritization score from 0 to 100. It is model output for watchlist review, not personalized financial advice.

    20 Low confidence Low
    Fundamentals Dec 31, 2025
    Price Jun 09, 2026
    Confidence Low

    Stored data quality

    Freshness and coverage checks

    Stored company inputs are available, but some dates or model fields are older or incomplete.

    11/16 Partial or delayed snapshot
    Fundamental period Dec 31, 2025 161 days old
    Price snapshot Jun 09, 2026 1 day old
    Input coverage 11/16 Stored fields powering this model output
    Confidence impact 5 gaps Missing fields reduce confidence and can limit signal detail

    Quality

    Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.

    0/35 Weak

    Financial Strength

    Financial strength rewards durable profitability, margins, and positive free cash flow.

    13/25 Mixed

    Valuation Support

    Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.

    2/15 Weak

    Momentum

    Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

    5/15 Weak

    Shareholder Alignment

    Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

    0/10 Weak

    Positive model output

    More live company inputs are needed before positive research signals can be surfaced.

    Research risks to review

    • Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.
    • Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.
    • Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

    MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting. Missing inputs right now include EPS rank, ROE rank, net margin rank, share-count rank, leverage rank.

    Overview Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Ratio
    Dashboard Funda..tals Deep..lue Prediction Screener Map

    XOMA Corp Overview

    Industry: Biotechnology

    Sector: Healthcare

    XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.

    XOMA Corp is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

    Score

    Price History & Performance

    Review XOMA Corp in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

    Recent News



    XOMA Corp Competitors

    XOMA Corp operates in the Biotechnology industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

    Earnings Per Share

    EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

    Continue the analysis

    Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

    View plans
    Ticker Image

    XOMA Corp

    US$25.40

    US$301.2m

    0.12%

    1.43%